Microbiome Sequencing Services Market Expected to Reach USD 2.52 Billion by 2030, Driven by Rising Clinical Trial Demand and NGS Adoption

Mordor Intelligence has published a new report on Microbiome Sequencing Services Market offering a comprehensive analysis of trends, growth drivers, and future projections.
Introduction

The Microbiome Sequencing Services Market [https://www.mordorintelligence.com/industry-reports/microbiome-sequencing-services-market?utm_source=abnewswire] size is estimated at USD 1.82 billion in 2025, and is expected to reach USD 2.52 billion by 2030, at a CAGR of 6.72% during the forecast period (2025-2030). This growth is largely fueled by increasing adoption of microbiome profiling in clinical trials, therapeutic discovery, and precision-medicine workflows. Falling costs of next-generation sequencing (NGS) have made advanced microbiome studies more accessible to both academic and commercial users, further expanding market opportunities. North America currently holds the largest share of the market, while Asia-Pacific is emerging as the fastest-growing region, reflecting growing research infrastructure and investment in biotechnology across the region.

Key Trends

Increasing Outsourcing to Specialized CROs

Pharmaceutical companies and contract research organizations (CROs) are increasingly outsourcing microbiome work to specialized CROs that can manage complex sampling, bioinformatics, and regulatory compliance. This trend accelerates project timelines and improves reproducibility in clinical trials, representing one of the fastest-growing segments within the microbiome sequencing services market.

Declining Cost of Next-Generation Sequencing (NGS)

The cost of next-generation sequencing has drastically decreased over the past two decades, making genome sequencing more accessible. This reduction allows more research organizations and smaller biotech firms to conduct microbiome studies, resulting in higher sample volumes and recurring analytical contracts. Service providers are differentiating themselves through integrated bioinformatics, regulatory-grade quality systems, and multi-omic data interpretation to maintain competitive advantages.

Venture Capital and Investment Growth

The surge in venture capital funding for microbiome-based therapeutics and companion diagnostics is supporting the market's expansion. Increased financial backing enables startups and established companies to invest in advanced sequencing technologies and bioinformatics capabilities, driving innovation and adoption across the industry.

National Biobank Initiatives

National biobank programs that incorporate longitudinal microbiome arms are creating additional demand for sequencing services. By collecting and analyzing microbiome data over time, these initiatives facilitate large-scale research and clinical studies, further expanding the market for specialized sequencing providers.

Check out more details and stay updated with the latest industry trends, including the Japanese version for localized insights:

https://www.mordorintelligence.com/ja/industry-reports/microbiome-sequencing-services-market?utm_source=abnewswire

Market Segmentation

The microbiome sequencing services market is segmented by sequencing service type, technology, application, end user, and geography. Each segment presents unique growth opportunities:

By Sequencing Service Type

*
16S rRNA Gene Sequencing

*
Shotgun Metagenomic Sequencing

*
Targeted Gene Panel Sequencing

*
Whole Genome and Metatranscriptomic Sequencing

*
Other Services

By Technology

*
Sequencing by Synthesis

*
Nanopore Sequencing

*
Sequencing by Ligation

*
Others

By Application

*
Gastrointestinal Diseases

*
Infectious Diseases

*
Oncology

*
CNS and Neurodegenerative Disorders

*
Others

By End User

*
Academic & Research Institutes

*
Pharmaceutical & Biotechnology Companies

*
Contract Research Organizations (CROs)

*
Hospitals & Diagnostic Laboratories

*
Others

By Geography

*
North America

*
South America

*
Europe

*
Asia pacific

*
Middle east&Africa

Key Players

*
Merieux Nutrisciences Corporations

*
Microbiome Insights Inc.

*
MR DNA

*
Baseclear BV

*
Clinical Microbiomics AS

Conclusion

The microbiome sequencing services market is positioned for sustained growth, driven by rising demand for precision medicine, increased outsourcing to specialized CROs, and falling NGS costs that broaden access. Companies that integrate multi-omic bioinformatics, maintain regulatory compliance, and deliver reliable clinical-grade results are likely to maintain competitive advantages. As adoption spreads across emerging regions and research applications expand, the market size is expected to reach USD 2.52 billion by 2030. Continued investment in microbiome-based therapeutics, companion diagnostics, and national biobank programs will provide ongoing opportunities for providers. The market's trajectory reflects not only the expanding role of microbiome research in healthcare but also the growing recognition of its impact on therapeutic development and patient outcomes.

Industry Related Reports:

Human Microbiome Market [https://www.mordorintelligence.com/industry-reports/human-microbiome-market?utm_source=abnewswire] : The Human Microbiome Market report provides a comprehensive analysis of the industry, segmented across multiple dimensions. By product, the market covers drugs, supplements, diagnostic tests, and other related products. In terms of application, it includes therapeutics and diagnostics, while the disease area segmentation addresses gastrointestinal disorders, cancer, and other relevant conditions. The market is also analyzed by end-users, such as hospitals, clinics, and other healthcare facilities. Geographically, the report examines key regions including North America, Europe, Asia-Pacific, the Middle East and Africa, and South America. Market forecasts are presented in terms of value (USD), offering insights into current trends and future growth potential.

North America DNA Sequencing Market [https://www.mordorintelligence.com/industry-reports/north-america-dna-sequencing-market?utm_source=abnewswire] : The North America DNA Sequencing Market is segmented based on several key factors. By product type, the market includes instruments, consumables such as kits and reagents, and other related products. In terms of sequencing type, it covers technologies like Sanger sequencing, next-generation sequencing, and additional methods. The market is also categorized by application, encompassing areas such as diagnostics, personalized medicine, and more. End users include hospitals and healthcare organizations, academic and research institutions, among others. Geographically, the market focuses on the United States and other regions within North America.

Direct-to-Consumer Laboratory Testing Market [https://www.mordorintelligence.com/industry-reports/direct-to-consumer-laboratory-testing-market?utm_source=abnewswire] : The Direct-to-Consumer (DTC) Laboratory Testing Market is segmented based on several key factors. By test type, the market includes genetic testing, routine clinical tests, microbiome testing, allergy and intolerance tests, among others. In terms of sample type, offerings cover saliva, blood, and additional sample formats. The market is also categorized by distribution channel, encompassing online direct sales, retail pharmacies and drug stores, and other channels. Geographically, the market spans regions such as North America, Europe, and more. Market forecasts are provided in terms of value (USD).

About Mordor Intelligence:

Mordor Intelligence is a trusted partner for businesses seeking comprehensive and actionable market intelligence. Our global reach, expert team, and tailored solutions empower organizations and individuals to make informed decisions, navigate complex markets, and achieve their strategic goals.

With a team of over 550 domain experts and on-ground specialists spanning 150+ countries, Mordor Intelligence possesses a unique understanding of the global business landscape. This expertise translates into comprehensive syndicated and custom research reports covering a wide spectrum of industries, including aerospace & defense, agriculture, animal nutrition and wellness, automation, automotive, chemicals & materials, consumer goods & services, electronics, energy & power, financial services, food & beverages, healthcare, hospitality & tourism, information & communications technology, investment opportunities, and logistics.

For any inquiries or to access the full report, please contact:

media@mordorintelligence.com https://www.mordorintelligence.com/

Media Contact
Company Name: Mordor Intelligence Private Limited
Contact Person: Jignesh Thakkar
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=microbiome-sequencing-services-market-expected-to-reach-usd-252-billion-by-2030-driven-by-rising-clinical-trial-demand-and-ngs-adoption]
Phone: +1 617-765-2493
Address:11th Floor, Rajapushpa Summit, Nanakramguda Rd, Financial District, Gachibowli
City: Hyderabad
State: Telangana 500008
Country: India
Website: https://www.mordorintelligence.com/

Legal Disclaimer: Information contained on this page is provided by an independent third-party content provider. ABNewswire makes no warranties or responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you are affiliated with this article or have any complaints or copyright issues related to this article and would like it to be removed, please contact retract@swscontact.com



This release was published on openPR.